The strategy of blocking the chemokine system to combat disease

Immunological Reviews

Volumn 177, Issue , 2000, Pages 246-256

  Proudfoot, A E I ^a   Power, C A ^a   Wells, T N C ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GLYCOSAMINOGLYCAN; MEMBRANE RECEPTOR;

CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0033652283     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17721.x     Document Type: Review

References (65)

1. Chemokines
2. Chemokines - Chemotactic cytokines that mediate inflammation
3. Chemokine receptors - Future therapeutic targets for HIV?
4. Definition, function and pathophysiological significance of chemokine receptors
5. Chemokines in health and disease
6. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 α/LD78α and chemotactic for T lymphocytes, but not for monocytes
7. HIV entry and tropism: The chemokine receptor connection
8. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
9. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes
10. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-γ in human neutrophils
11. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses
12. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1α
13. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1α by mutagenesis of the proteoglycan binding site
14. Glycosaminoglycans mediate cell surface oligomerization of chemokines
15. The effects of human macrophage inflammatory protein-1 α and its genetically modified variant, BB10010, on phagocyte function
16. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity
17. Chemokine signaling in inflammation
18. Chemokine-induced signal transduction in leukocytes
19. IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D
20. Rantes activation of phospholipase D in jurkat T cells - Requirement of GTP-binding proteins ARF and RHOa
21. Dissociation of chemotaxis from agonist-induced receptor internalization in a lymphocyte cell line transfected with CCR2B. Evidence that directed migration does not require rapid modulation of signaling at the receptor level
22. Chemokines and T lymphocytes - More than an attraction
23. RANTES and MIP-1-α activate Stats in T cells
24. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
25. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus
26. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor
27. Differential activation of CC chemokine receptors by AOP-RANTES
28. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
29. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization
30. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line
31. Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4
32. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
33. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4
34. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock
35. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia
36. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
37. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis
38. MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation
39. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
40. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3
41. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors
42. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice
43. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model
44. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment
45. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
46. Recent developments in modulating chemokine networks
47. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration
48. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
49. Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: Synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety
50. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
51. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
52. Discovery of novel non-peptide CCR1 receptor antagonists
53. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor
54. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
55. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury
56. Decreased lesion formation in CCR2 -/- mice reveals a role for
57. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor
58. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
59. Neutrophil and B cell expansion in mice that lack the murine IL- 8 receptor homolog
60. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
61. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
62. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen
63. Chemokine receptors: Gateways to inflammation and infection
64. Chemokines: A new classification system and their role in immunity